Design, Synthesis, and Evaluation of Salicyladimine Derivatives As Multitarget-Directed Ligands Against Alzheimer's Disease.

Hua-Li Yang,Pei Cai,Qiao-Hong Liu,Xue-Lian Yang,Si-Qiang Fang,Yan-Wei Tang,Cheng Wang,Xiao-Bing Wang,Ling-Yi Kong

DOI: https://doi.org/10.1016/j.bmc.2017.08.048

IF: 3.461

2017-01-01

Bioorganic & Medicinal Chemistry

Abstract:•Novel multi-target-directed ligands for Alzheimer's disease were designed and synthesized.•Most of the target compounds have inhibitory activities against amyloid-β (Aβ) aggregation and hMAO-B as well as remarkable antioxidant effects.•Compound 5 exhibited excellent potency for inhibition of self-induced Aβ1–42 aggregation (91.3±2.1%, 25μM) and inhibition of hMAO-B (IC50, 1.73±0.39μM).•Compound 5 showed antioxidant activitities, metal-chelating properties, neuroprotective effects, significant in vitro anti-inflammatory activity and potent BBB penetration.